BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Dong ZB, Wu HM, He YC, Huang ZT, Weng YH, Li H, Liang C, Yu WM, Chen W. MiRNA-124-3p.1 sensitizes hepatocellular carcinoma cells to sorafenib by regulating FOXO3a by targeting AKT2 and SIRT1. Cell Death Dis 2022;13:35. [PMID: 35013144 DOI: 10.1038/s41419-021-04491-0] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Zhou X, Ao X, Jia Z, Li Y, Kuang S, Du C, Zhang J, Wang J, Liu Y. Non-coding RNA in cancer drug resistance: Underlying mechanisms and clinical applications. Front Oncol 2022;12:951864. [PMID: 36059609 DOI: 10.3389/fonc.2022.951864] [Cited by in Crossref: 1] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
2 Wang C, Tu X, Jiang Y, Jiao P, Deng X, Xie Y, Zhang L. Prognostic value of high FOXO3a expression in patients with solid tumors: A meta-analysis and systematic review. Int J Biol Markers 2022;:3936155221095879. [PMID: 35484793 DOI: 10.1177/03936155221095879] [Reference Citation Analysis]